Fructose 1,6-bisphosphatase 1 is a potential biomarker affecting the malignant phenotype and aerobic glycolysis in glioblastoma
Background Fructose 1,6-bisphosphatase 1 (FBP1) has been considered as a potential prognostic biomarker in glioblastoma (GBM), and this study explored the underlying mechanism.Methods The expression and effect of FBP1 expression on the prognosis of GBM patients were examined applying bioinformatics analyses.After measuring the expression of FBP1 in